文献速递先天性心脏病外科心外重症与机械循环支持

儿童系统性房室瓣切除与心室辅助装置的应用

Systemic Atrioventricular Valve Excision and Ventricular Assist Devices in Pediatric Patients.
PubMed 文献 · Ann Thorac Surg · 2017-08-16

病例包括1例15岁系统性右心室患者和2例小于4岁的Fontan术后患者(体表面积0.62 m²和0.58 m²)。术后平均随访359天(范围304-422天),未出现流入道梗阻或低流量迹象,表明该技术可成功支持复杂儿科患者。

要点

  • 系统性房室瓣切除可避免儿童CF VAD流入道梗阻
  • 小体型和系统性右心室患者也可成功植入CF VAD
  • 术后随访未发现流入道梗阻或低流量

核心结论

  • CF VAD植入联合房室瓣切除可成功支持不同体型和解剖结构的复杂儿科患者,包括小心室和系统性右心室。

主要发现

  • 患者1为15岁系统性右心室患者,术后第52天因三尖瓣梗阻行三尖瓣切除。
  • 患者2和3年龄小于4岁,体表面积分别为0.62 m²和0.58 m²,均为Fontan术后,在右心房植入CF VAD并同期切除房室瓣。
  • 平均随访359天(范围304-422天),无流入道梗阻或低流量迹象,无房压升高或顽固性肺水肿证据。

临床怎么用

  • 对于因尺寸和解剖导致流入道梗阻风险高的儿科患者,可考虑在CF VAD植入时同期行房室瓣切除。
  • 该技术可能使先前因体型过小而被认为不适合CF VAD的患者获得支持。

局限性

  • 回顾性研究,样本量小(3例),随访时间有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Continuous-flow ventricular assist devices (CF VADs) designed for adults are increasingly used in pediatric patients. However, there is greater risk of device inflow obstruction as a result of size and anatomy. METHODS: We reviewed all cases of systemic atrioventricular valve (AVV) excision with HeartWare HVAD (HeartWare, Framingham, MA) implantation in the systemic ventricle performed at our institution from November 2015 to May 2016. RESULTS: AVV excision with CF VAD implantation was undertaken in 3 patients. Patient 1 was palliated in infancy, resulting in biventricular physiology with a systemic right ventricle, and presented at age 15 years with worsening ventricular dysfunction. After CF VAD implantation in the systemic ventricle and discharge to home, tricuspid valve obstruction to VAD inflow developed, and the patient and underwent tricuspid valve excision on postoperative day 52. Patients 2 and 3 were aged younger than 4 years, with a body surface area of 0.62 m2 and 0.58 m2, respectively, and had undergone Fontan palliation, with subsequent systemic ventricular dysfunction and AVV regurgitation. In both Fontan patients, the CF VAD was implanted in the right atrium with simultaneous excision of the AVV. None have had evidence of elevated atrial pressures or recalcitrant pulmonary edema. At a mean follow-up of 359 days (range, 304 to 422 days), there have been no concerns for inflow obstruction or low flow. CONCLUSIONS: CF VAD implantation with AVV excision can successfully support complex pediatric patients in a wide range of size and anatomy (small chambers, systemic right ventricles). This technique may allow for CF VAD implantation in patients previously deemed too small for such support.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Nandi D, Miller KD, Bober CM, et al. Systemic Atrioventricular Valve Excision and Ventricular Assist Devices in Pediatric Patients. Ann Thorac Surg. 2017. PMID: 28821330. doi:10.1016/j.athoracsur.2017.05.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。